rs782323741

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BS2

The NM_000052.7(ATP7A):​c.3790A>G​(p.Ile1264Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,208,859 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1264T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000012 ( 0 hom. 5 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

5
7
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 9.20

Publications

1 publications found
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000052.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 9 uncertain in NM_000052.7
BS2
High AC in GnomAdExome4 at 13 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000052.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
NM_000052.7
MANE Select
c.3790A>Gp.Ile1264Val
missense
Exon 19 of 23NP_000043.4Q04656-1
ATP7A
NM_001282224.2
c.3556A>Gp.Ile1186Val
missense
Exon 18 of 22NP_001269153.1Q04656-5
ATP7A
NR_104109.2
n.963A>G
non_coding_transcript_exon
Exon 6 of 10

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
ENST00000341514.11
TSL:1 MANE Select
c.3790A>Gp.Ile1264Val
missense
Exon 19 of 23ENSP00000345728.6Q04656-1
ATP7A
ENST00000689767.1
c.3883A>Gp.Ile1295Val
missense
Exon 21 of 25ENSP00000509406.1A0A8I5KWA8
ATP7A
ENST00000343533.10
TSL:5
c.3820A>Gp.Ile1274Val
missense
Exon 20 of 24ENSP00000343026.6A0A8J9FM07

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
111975
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000975
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1096884
Hom.:
0
Cov.:
30
AF XY:
0.0000138
AC XY:
5
AN XY:
362294
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26371
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19377
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30185
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54109
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40521
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4114
European-Non Finnish (NFE)
AF:
0.0000155
AC:
13
AN:
840953
Other (OTH)
AF:
0.00
AC:
0
AN:
46048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
111975
Hom.:
0
Cov.:
22
AF XY:
0.0000293
AC XY:
1
AN XY:
34125
show subpopulations
African (AFR)
AF:
0.0000975
AC:
3
AN:
30780
American (AMR)
AF:
0.00
AC:
0
AN:
10507
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3611
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2721
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5996
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53267
Other (OTH)
AF:
0.00
AC:
0
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.089
D
MetaRNN
Uncertain
0.62
D
MetaSVM
Uncertain
0.59
D
MutationAssessor
Benign
0.76
N
PhyloP100
9.2
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.86
N
REVEL
Uncertain
0.61
Sift
Benign
0.036
D
Sift4G
Benign
0.079
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.36
gMVP
0.91
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs782323741;
hg19: chrX-77296220;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.